Hosted by Mark Wade of TransPerfect Life Sciences, LifeSci Talks is an informal, informative conversation that focuses on a variety of themes and topics in the life sciences space. Featuring thought leaders and industry experts from different therapeutic areas and divisions, the discussions provide actionable takeaways and topical insights into current global challenges and opportunities.
All content for LifeSci Talks is the property of TransPerfect Life Sciences and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Hosted by Mark Wade of TransPerfect Life Sciences, LifeSci Talks is an informal, informative conversation that focuses on a variety of themes and topics in the life sciences space. Featuring thought leaders and industry experts from different therapeutic areas and divisions, the discussions provide actionable takeaways and topical insights into current global challenges and opportunities.
PRO Scheduling Considerations: Assessing Patient & Caregiver Burden in Clinical Trials
LifeSci Talks
19 minutes 41 seconds
1 year ago
PRO Scheduling Considerations: Assessing Patient & Caregiver Burden in Clinical Trials
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd Consulting, to spotlight the burden of clinical research for patients, and their caregiver/family dynamics. From ethical considerations surrounding patient/caregiver consent, to the intricate timing challenges of data collection, the conversation examines how involvement in a study impacts on disease states and patient wellbeing, with further insight into how burden is extended to families and caregivers.
LifeSci Talks
Hosted by Mark Wade of TransPerfect Life Sciences, LifeSci Talks is an informal, informative conversation that focuses on a variety of themes and topics in the life sciences space. Featuring thought leaders and industry experts from different therapeutic areas and divisions, the discussions provide actionable takeaways and topical insights into current global challenges and opportunities.
